What You’ll Learn in This Video

What You’ll Learn in This Video

• POI ≠ Menopause ≠ Ovarian Failure – Ovarian function may fluctuate; rare spontaneous pregnancy possible.
• Diagnosis – FSH ≥25 IU/L + ≥4 months amenorrhea; single FSH sufficient; AMH & ultrasound optional.
• Etiology – Always evaluate: Karyotype, FMR1, 21-hydroxylase antibodies; TSH only.
• Hormone Therapy – Life-saving; higher-dose estrogen (transdermal preferred); add progesterone if uterus present.
• HRT ≠ Contraception – Ovulation may occur; spontaneous pregnancy rare.
• Local Vaginal Estrogen – Estriol cream safe, effective for dryness, dyspareunia, urinary symptoms; systemic estradiol requires progesterone.
• Fertility Counseling – Egg/embryo donation is gold standard; individualized based on uterus, bleeding preference, contraception needs.
• Long-Term Monitoring – Bone, heart, mental health; ensure therapy adherence and psychological well-being

What You’ll Learn in This Video

What You’ll Learn:

• Why IVF protocols have shifted from “one-size-fits-all” to Individualized COS AMH cut-offs for High, Normal, and Poor ovarian responders
• POSEIDON classification and treatment strategies for Group 3 & Group 4 low-reserve patients
• P Recommended FSH/LH dosing:
  • High responders → lower FSH to prevent OHSS
  • Normal responders → standard 150–225 IU
  • Poor responders → ~300 IU FSH ± LH support
• Advanced stimulation methods: Dual Stimulation (DuoStim), Multi-Cycle Embryo Banking, Agonist Stop, and PPOS protocols
• Pre-treatment options: estradiol valerate, antagonist or agonist scheduling for better cohort synchronization
• HMG vs Recombinant FSH – evidence, cost, and quality considerations
• Trigger choices (hCG vs GnRH agonist) and luteal support for safe fresh transfers

Key Takeaways

• HH is rare but treatable
• Diagnosis: detailed hormonal and imaging evaluation
• Pre-treatment with estrogen/progesterone essential for uterine preparation
• Gonadotropin stimulation may take 20–30 days
• Use both FSH and LH; recombinant preparations can offer consistent response
• AMH/AFC are unreliable predictors
• Luteal support: progesterone + estrogen ± hCG
• Donor eggs often not required with patience and correct stimulation

Key takeaways from the talk include:

• International PCOS Guidelines (2023): First-line Letrozole vs. Clomiphene
• When to start stimulation & monitoring tips
• Low-dose step-up gonadotropin regimen
• Managing resistant PCOS & FSH receptor issues
• Endometrium management & breakthrough bleeding
• Fresh vs. frozen embryo transfer decisions
• Role of ovarian drilling, IVM, and LH supplementation

Key takeaways from the talk include:

• The role of endometrial thickness in ART and its impact on pregnancy rates.
• The importance of monitoring endometrial thickness during frozen embryo transfer (FET).
• Hormonal approaches like Estradiol therapy, and the use of transdermal and vaginal routes.
• The potential of vascular therapies like Sildenafil and the promising future of regenerative treatments like PRP (Platelet-Rich Plasma) and Stem Cell therapy.
• Insights into the management of chronic endometritis and other underlying causes of thin endometrium.

Key Takeaways:

• HH is rare but accounts for 1-3% of infertility cases.
• Both congenital and acquired forms require careful diagnosis.
• Gonadotropin therapy is crucial for ovulation induction.
• Be patient during ovarian stimulation—treatment can take up to 30 days.
• The risk of multiple pregnancies and OHSS is higher in HH patients.

Key Takeaways:

• AMH is a critical marker in determining ovarian reserve and predicting response to stimulation.
• Individualized protocols improve the chances of live birth while minimizing complications like OHSS and multiple pregnancies.
• The evolution of IVF protocols over the decades has led to more patient-friendly and effective treatment options.
• Poor responders can benefit from advanced techniques like double stimulation and adjunctive treatments, including growth hormones and androgens.
• Pre-treatment and careful management of stimulation doses are vital in optimizing egg retrieval, especially for patients with low ovarian reserve.

What You’ll Learn:

• The physiology of the luteal phase in natural vs. stimulated cycles
• Why Luteal Phase Support matters in IVF treatments
• How to optimize LPS: balancing hormones—not less, not more
• Evidence-based protocols and recent advances
• Common mistakes in LPS and how to avoid them
• Personalized medicine in luteal support

Topics Covered:

• What Social Egg Freezing Is
• Reasons for Popularity
• The Science Behind It
• Success Rates and Challenges
• Patient Experiences
• Embryo Freezing vs. Egg Freezing
• Costs and Storage
• Emotional Impact
• Is It Worth It?

Topics Covered:

• What is Recurrent Pregnancy Loss (RPL)?
• Differences in international guideline definitions (ASRM, RCOG, EULAR)
• Structured diagnostic workup
• Immune, genetic, anatomical, and endocrine factors
• Role of antiphospholipid syndrome (APS)
• Do’s and Don’ts: Bed rest, empirical therapy, lifestyle
• Psychological and supportive care for couples
• Final recommendations for unexplained RPL

What You Will Learn:

• Key differences in symptoms & diagnosis of PCOS vs NCCAH
• When to suspect Non-Classic CAH in “PCOS-like” cases
• Role of 17-OHP, ACTH stimulation test, and genetic testing
• Management strategies: OCPs, Metformin, Glucocorticoids, Ovulation Induction Reproductive counseling & prenatal care in NCCAH
• Why early detection of CH in neonates is life-saving ?
• Risks of prenatal Dexamethasone: What does current evidence say?
• Special Focus:

Genetic risks in NCCAH: What to test before planning pregnancy
Preventing ambiguous genitalia in female fetuses: What’s the controvers
Monitoring protocols for PCOS patients (OGTT, Lipids, BP)

What You’ll Learn in This Video:

• Understanding Poor Ovarian Reserve (POR)
• Causes & Risk Factors
• Symptoms of Diminished Ovarian Reserve
• How It’s Diagnosed
• Treatment Options
• IVF & Poor Ovarian Reserve
• Fertility Preservation
• Advancements in Fertility Science

What’s Inside:
Masterclass Highlights

• By Dr Abha Majumdar and Sr. Embroyologist Gaurav Majumdar
Optimizing IVF outcomes, understanding embryo quality, fertilization methods, and lab KPIs
• Modern protocols: single embryo transfer, ovarian stimulation, and patient-specific approaches
• Managing special cases such as PCOS, endometriosis, prothrombotic patients, oncologic patients, and advanced maternal age
• Launch of a coffee table book honoring Dr. Majumdar’s contributions, philanthropy, and mentorship
• Reflections from colleagues on her integrity, creativity, empathy, and work-life balance
• Audience Q&A on IVF vs ICSI, ovarian stimulation, and advanced infertility managementv

What you will learn in this video:

• Key factors behind Recurrent Implantation Failure (RIF)
• The role of progesterone and endometrial health in successful implantation
• Understanding Chronic Endometritis (CE) and its impact
• Why certain IVF add-ons are not recommended for RIF treatment
• A “Minimalist” approach for managing IVF failures
• Practical evaluation and therapeutic options for RIF patients

What You’ll Learn in This Session:

• Understanding the Window of Implantation (WOI) and hormonal orchestration
• Indications for FET over fresh transfer: OHSS risk, thin lining, PGT, donor cycles, ectopic history, and more
• Detailed comparison of 3 key endometrial preparation protocols:
  • Natural Cycle FET (True & Modified)
  • Stimulated Cycle FET
  • Hormone Replacement Therapy (HRT) Cycle

This video covers:

• What is DUO‑STIM?
• Why it’s ideal for poor ovarian responders, women of advanced maternal age, and fertility preservation (e.g. cancer patients).
• Scientific basis of multi-wave follicular recruitment
• How PPS (Progestin-Primed Stimulation) supports flexible, cost-effective cycles
• Protocol variations, triggers, and cryopreservation strategies
• Clinical outcomes and when to use mild stimulation or Clomid-only approaches
• Important practical tips for IVF clinicians
• Ethical considerations and patient counseling

What You’ll Learn in This Video

• What is Pre-implantation Genetic Testing (PGT)?
• When should PGT be considered?
• The PGT process step-by-step
• Benefits and Limitations of PGT in IVF
• Ethical Consideration of PGT in IVF
• Cost-effectiveness and patient selection

What You’ll Learn in This Video

• Why genital TB is an important but often overlooked cause of infertility
• How TB spreads to the reproductive tract
• Key clinical signs that should raise suspicion
• Which patients need testing and what investigations are most reliable
• Step-by-step diagnostic approach (from basic screening to advanced testing)
• Treatment principles and fertility outcomes after TB

By the end of this masterclass, viewers will understand

• Why transferring more than one embryo increases maternal-fetal risk
• How elective single embryo transfer (eSET) reduces obstetric and neonatal complications
• When (and when not) DET may be considered
• What determines the ideal number of embryos to transfer in different age groups
• How to counsel patients effectively about embryo transfer decisions
• Why fetal reduction is not a justifiable strategy after DET
• How clinics can adopt safer IVF practices without compromising success rates

What You’ll Learn:

• FSH & LH: Core to IVF Success
• Recombinant > Urinary Gonadotropins
• Genetic Variations Matter
• Personalized Dosing is Critical
• Optimize for Age-Related Decline
• HCG ≠ LH During Stimulation
• Tackle Empty Follicle Syndrome
• Fertility Preservation Protocols
• Minimal Stimulation ≠ Ideal for All
• Individualized IVF = Better Outcomes

What You’ll Learn in This Video:

• PCOS in Teens vs Adults – Key differences in diagnosis and management.
• Diagnostic Criteria – Irregular periods + hyperandrogenism are key.
• Menstrual Irregularity – What’s normal in the first 3 years post-menarche.
• Ovulatory Dysfunction – Confirm with serum progesterone.
• Why Early Diagnosis Can Be Harmful – Avoid premature labeling.
• First-Line Treatment – Lifestyle changes (diet, exercise) are essential.
• Medication Options – COCs, Metformin, Progestins for menstrual issues; Anti-androgens for acne/ hirsutism.
• Mental Health – Address anxiety, body image, and provide counseling.
• Monitoring – Regular check-ups for weight, metabolic health, and symptom progression.
• Luteal Phase Support in IVF – Importance of progesterone for early pregnancy support.

What You’ll Learn in This Masterclass on Unexplained Infertility:

• What defines unexplained infertility and why routine tests miss key steps
• Evidence-based treatment approach: Expectant management, IUI, and IVF
• When to choose IUI vs. when to proceed directly to IVF based on age and prognosis
• Key clinical trial insights guiding current management protocols
• Role of sexual function and male factor assessment in infertility workup
• Best practices for medication use, cycle monitoring, and luteal phase support
• Cost-effective strategies to shorten time-to-pregnancy and improve success rates

In this session, Dr. Majumdar explains:

• Why AMH is not a predictor of natural fertility or oocyte quality
• How AMH is best used in IVF/IUI planning and ovarian stimulation protocols
• Important nuances in AMH testing (age, cycle regularity, OCP use, surgery)
• Evidence-based counseling for women with low AMH
• Latest updates on PRP, stem cell therapy, and early follicular recruitment

Whether you’re a fertility specialist, gynecologist, or student, this masterclass delivers practical pearls for everyday practice.

What You’ll Learn:

• IVF protocols simplified
• Luteal support and hormonal treatments
• Embryo transfer strategies
• IUI and ovulation induction
• Case studies and live Q&As

Topics Covered:

• What is the Luteal Phase?
• What is Luteal Phase Deficiency (LPD)?
• Why does LPD occur in stimulated cycles and IVF?
• Individualized luteal support for fresh and frozen embryo transfer cycles.
• Use of Progesterone, HCG, Estrogen, and GnRH in luteal support.
• Clinical guidelines and evidence-based recommendations.

What You Will Learn in This Session:

·
• Treat overt hypothyroidism and monitor subclinical cases
• Only treat high prolactin if ovulation is impaired
• Use ACTH testing to confirm NCCAH
• Micronized vaginal progesterone = gold standard for luteal support

What You Will Learn in This Session:

• How to evaluate and select ideal patients for IUI
• Semen analysis interpretation based on WHO 2021 criteria
• The impact of timing, ovulation monitoring, and cycle selection
• Role of sperm preparation techniques in IUI success
• When to use single vs. double IUI
• Managing male factor infertility – Oligospermia, Asthenospermia, Teratozoospermia
• Role of antioxidants, hormone therapy, and lifestyle changes
• Special situations: Retrograde ejaculation, Globozoospermia, HIV-positive partners
• ART referrals – When and why?
• Clinical pearls from real-world OPD scenarios

What You Will Learn in This Session:

• How to interpret semen analysis reports using WHO 2021 reference values
• When and how to repeat semen analysis based on motility or volume abnormalities
• How to approach low sperm count (OAT) with lifestyle, medical, or ART options
• Stepwise evaluation of azoospermia – obstructive vs. non-obstructive
• Hormonal profiles to assess male fertility: FSH, LH, testosterone
• Medical management strategies: HCG, FSH, aromatase inhibitors, antioxidants
• Genetic testing indications: Karyotyping, Y-chromosome microdeletions, CFTR mutations
• When to refer to a urologist or ART specialist for advanced care
• Common myths debunked: First vs. second ejaculate, sperm morphology benchmarks
• ART decision-making: IUI vs. IVF vs. ICSI for different male infertility profiles
• Case-based insights: Globozoospermia, retrograde ejaculation, HIV-positive men

What You’ll Learn in this Masterclass:

• Reframing infertility as a condition — not a defect or disease — to break societal stigma.
• The emotional and psychological impact of infertility, and how to build resilience.
• Exploring treatment as a choice, not a necessity — and understanding all your options.
• Holistic lifestyle support for fertility: nutrition, stress management, and wellness.
• Creating supportive relationships and communities during the fertility journey.

What you will learn in this video

• Master Ovarian Stimulation AMH | AFC | FSH – Explained
• High vs. Poor Responders
• Customize IVF Protocols
• Avoid OHSS in IVF
• GnRH: Agonist or Antagonist?
• Fresh vs. Freeze-All?
• Individualized IVF Made Easy

What you will learn in this video

• Endometeriosis Risks: Infections, abscess, PoorFollicle Access.
• Adenomyosis Impact: >98.8cc -> higher Miscarriages and Lower Live Births
• Dienogest Vs GnRH :- When to use each before IVF
• Surgery or Suppression? Personalized approach based on symptoms, volumes
• Key Strategies Segmented Cycles, Modified Natural FET, PPOS Update.

What you will learn in this video

• What You’ll Learn in this video
• Why IVF stimulation protocols need to be tailored specifically for endometriosis patients?
• How endometriosis impacts ovarian reserve, oocyte quality, and the implantation environment?
• Comparative analysis of pre-treatment strategies: surgical intervention vs. medical suppression
• The role of GnRH agonist and antagonist protocols, including the benefits and limitations of ultra-long down regulation
• Use of Dienogest, oral contraceptive pills (OCPs), and aromatase inhibitors for inflammation control before IVF
• How to manage poor responders and optimize LH supplementation during stimulation?
• The clinical utility of the Endometrial Receptivity Array (ERA) in patients with suspected implantation failure
• Why cyst aspiration of endometriomas before or during stimulation is generally discouraged due to potential risks?
• Practical takeaways and protocol recommendations from leading reproductive medicine experts

What you will learn in this video

• Understanding Ovalution Dysfunction
• First and Second Line Therapies
• Ultrasound and Ovalution Monitoring
• Managing Oral Agent Failure
• Gonadotrophin Protocols and FSH Resistance
• Practical Tips and Case Discussions